Skip to content

hipEOS 3.x

by Onefit Medical

hipEOS 3.x is a Class II device made by Onefit Medical, cleared under FDA 510(k) K173390 on 27 Apr 2018 and listed in FDA GUDID since 24 May 2018 (UDI-DI 03700757200834), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K173390

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number03700757200834 UDI-DI Date24 May 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK173390 Date27 Apr 2018DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K173390 decided 27 Apr 2018 Active
  • FDA GUDID UDI-DI 03700757200834 listed 24 May 2018 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K173390
  2. Listed FDA GUDID 03700757200834

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
hipEOS
Generic name
Orthopaedic/craniofacial implantation planning software
Model / reference
3.x
Primary DI / UDI-DI
03700757200834
510(k) Number
FDA product code
LLZ
GMDN term
Orthopaedic/craniofacial implantation planning software
Device class
Class II
Regulation number
892.2050
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Orthopaedic/craniofacial implantation planning software.

Other devices from Onefit Medical

  • spineEOS 1.x

    Class II
  • Onefit Hip Planner

    Class II
  • HipEOS

    Class II
  • kneeEOS

    Class II

See all devices from Onefit Medical →

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)